{"id":32335,"date":"2018-08-13T12:00:00","date_gmt":"2018-08-13T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/"},"modified":"2018-08-13T12:00:00","modified_gmt":"2018-08-13T12:00:00","slug":"positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/","title":{"rendered":"Positionnement de Dymista dans le traitement de la rhinite allergique"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1378 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<h2>Rhinology Future Debates Bruxelles 2017<\/h2>\n<p>D\u00e9bat sur le positionnement de Dymista, un traitement nasal de la rhinite allergique. Dymista est un traitement symptomatique contenant un antihistaminique (az\u00e9lastine) et un corticost\u00e9ro\u00efde (propionate de fluticasone). <\/p>\n<h3>Pan\u00e9listes<\/h3>\n<p>Dr David Price, Dr Glenis Scadding, Dr Emmanuel Prokopakis, Dr Wytske Fokkens, Dr Oliver Pfaar, Dr Peter Hellings, Dr Claus Bachert et Dr Jean Bousquet.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1379 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><center><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/_GuPUayz1hs?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/center><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Rhinology Future Debates Bruxelles 2017 D\u00e9bat sur le positionnement de Dymista, un traitement nasal de la rhinite allergique. Dymista est un traitement symptomatique contenant un antihistaminique (az\u00e9lastine) et un corticost\u00e9ro\u00efde (propionate de fluticasone). Pan\u00e9listes Dr David Price, Dr Glenis Scadding, Dr Emmanuel Prokopakis, Dr Wytske Fokkens, Dr Oliver Pfaar, Dr Peter Hellings, Dr Claus Bachert et Dr Jean Bousquet.<\/p>\n","protected":false},"author":1,"featured_media":32355,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[189],"tags":[191,192,269,172,190],"class_list":["post-32335","news","type-news","status-publish","has-post-thumbnail","hentry","category-rhinology-future-debates","tag-debats","tag-rhinology-future-debates","tag-rhinite-allergique-ra","tag-asthme","tag-rhinologie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.3 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Positionnement de Dymista dans le traitement de la rhinite allergique - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Positionnement de Dymista dans le traitement de la rhinite allergique\" \/>\n<meta property=\"og:description\" content=\"Rhinology Future Debates Bruxelles 2017 D\u00e9bat sur le positionnement de Dymista, un traitement nasal de la rhinite allergique. Dymista est un traitement symptomatique contenant un antihistaminique (az\u00e9lastine) et un corticost\u00e9ro\u00efde (propionate de fluticasone). Pan\u00e9listes Dr David Price, Dr Glenis Scadding, Dr Emmanuel Prokopakis, Dr Wytske Fokkens, Dr Oliver Pfaar, Dr Peter Hellings, Dr Claus Bachert et Dr Jean Bousquet.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/\",\"name\":\"Positionnement de Dymista dans le traitement de la rhinite allergique - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017.png\",\"datePublished\":\"2018-08-13T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/Rhinology20Future20Debates202017.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Positionnement de Dymista dans le traitement de la rhinite allergique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Positionnement de Dymista dans le traitement de la rhinite allergique - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/","og_locale":"fr_FR","og_type":"article","og_title":"Positionnement de Dymista dans le traitement de la rhinite allergique","og_description":"Rhinology Future Debates Bruxelles 2017 D\u00e9bat sur le positionnement de Dymista, un traitement nasal de la rhinite allergique. Dymista est un traitement symptomatique contenant un antihistaminique (az\u00e9lastine) et un corticost\u00e9ro\u00efde (propionate de fluticasone). Pan\u00e9listes Dr David Price, Dr Glenis Scadding, Dr Emmanuel Prokopakis, Dr Wytske Fokkens, Dr Oliver Pfaar, Dr Peter Hellings, Dr Claus Bachert et Dr Jean Bousquet.","og_url":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/","url":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/","name":"Positionnement de Dymista dans le traitement de la rhinite allergique - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017.png","datePublished":"2018-08-13T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/Rhinology20Future20Debates202017.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/fr\/news\/positionnement-de-dymista-dans-le-traitement-de-la-rhinite-allergique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/fr\/news\/"},{"@type":"ListItem","position":3,"name":"Positionnement de Dymista dans le traitement de la rhinite allergique"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/fr\/#website","url":"https:\/\/www.euforea.org\/fr\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/fr\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/32335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=32335"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/32335\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/32355"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=32335"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=32335"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=32335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}